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Abstract In the adrenal cortex, corticotropin induces the
expression of several genes encoding proteins involved in
the synthesis and intracellular transport of steroid hor-
mones via the protein kinase A (PKA) signalling pathway,
and this process is mediated by steroidogenic factor-1 (SF-
1). This study was designed to elucidate the influence of
the PKA and PKC pathways on the expression of the SF-1
gene in mouse adrenocortical cells, line Y-1. It has also
been attempted to answer the question whether or not SF-1
plays a role in the PKA-induced expression of LIPE gene
encoding hormone-sensitive lipase/cholesteryl esterase,
which supplies cholesterol for steroid hormone synthesis.
In this study, we found that stimulation of the PKA path-
way caused a significant increase in SF-1 expression, and
that this effect was abolished by the PKA inhibitor, H89.
Decreased SF-1 gene transcript levels were seen with the
simultaneous activation of PKA and PKC, suggesting a
possible interaction between the PKA and PKC pathways.
It was also observed that SF-1 increased the transcriptional
activity of the LIPE gene by interacting with the SF-1
response element located in promoter A. Moreover, tran-
sient silencing of SF-1 expression with specific siRNAs
abolished PKA-stimulated transcription of the LIPE gene,
indicating that SF-1 is an important regulator of LIPE
expression in Y-1 cells and thus could play a role in the
regulation of the cholesterol supply for adrenal
steroidogenesis.
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Introduction
The synthesis and secretion of steroid hormones in the
adrenal cortex is regulated by corticotropin (ACTH),
secreted by the anterior pituitary. Upon binding to a
specific receptor (melanocortin type 2 receptor) via the Gs
protein, ACTH activates the membrane-bound adenylyl
cyclase, causing an increase in the intracellular concen-
tration of cAMP, an activator of the PKA. Increased con-
centration of cAMP, and thereby increased activity of the
PKA, can be achieved in vitro by treatment of the cells
with forskolin, which directly activates adenylyl cyclase.
In the adrenal cortex, ACTH acts via the PKA pathway
to induce the expression of genes encoding proteins
involved in the synthesis and intracellular transport of
steroid hormones [1–3] as well as the supply of substrate,
cholesterol, stored in lipid droplets. These actions are
mediated by steroidogenic factor-1 (SF-1), which induces
the expression of genes encoding members of the cyto-
chrome P450 (CYP) superfamily, as well as the genes
encoding ACTH receptor, and transporting proteins
including steroidogenic acute regulator (StAR) [4–6].
In the adrenal cortex, hormone-sensitive lipase/c-
holesteryl esterase (HSL) catalyses the hydrolysis of fatty
acyl esters of cholesterol and acts as a supplier of choles-
terol for steroid hormone synthesis. Numerous investiga-
tions have shown that HSL is activated by the covalent
phosphorylation of Ser563 and Ser660 residues in its regu-
latory domain. These reactions are catalysed by a cAMP-
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dependent PKA whose activity is increased by ACTH at a
posttranslational level [7]. HSL is encoded by the LIPE
gene (a member of the LIP gene family) and is located on
chromosome 19q13.3. This gene is composed of nine exons
plus additional six, which are transcribed in a tissue-de-
pendent fashion by tissue-specific promoters. In the adrenal
cortex, the transcription is regulated by promoter A [8, 9]
and the principal regulator of LIPE expression is ACTH
[10].
Based on our understanding of the mechanisms that
regulate the synthesis of steroidogenic enzymes, it can be
assumed that HSL is controlled not only by switching on
and off the catalytic activity of the enzyme, which con-
stitutes a short-term regulation, but also by the activation of
LIPE gene expression, encoding HSL, which represents a
long-term effect. Moreover, by drawing an analogy to
proteins encoded by the other genes associated with
steroidogenesis, it is possible that transcription factor SF-1
affects the transcriptional activity of the LIPE gene in
response to stimulation by ACTH.
It has been reported that SF-1 expression is essential for
survival and that SF-1(-/-) mice normally die at E8 due
to the lack of corticosteroids, unless they are rescued by the
administration of synthetic hormones [11]. SF-1 regulates
the expression of genes involved in differentiation of
gonads, sex determination [12] and steroidogenesis. The
role of SF-1 in activating of steroidogenic enzyme pro-
moters has been defined for CYP11A1, CYP11B1,
CYP11B2, CYP17, CYP19, CYP21 and DAX-1 [4, 13–15].
SF-1 activates the basic expression of these genes and
additionally controls the entry of cholesterol into the cells
by controlling the expression of ACTH, LDL and HDL
receptors, intracellular cholesterol transporters (sterol car-
rier protein 2, and SCP-2) [16, 17] and the StAR protein
(steroidogenic acute regulatory protein), which transports
cholesterol from the outer to the inner mitochondrial
membrane [18]. In addition, SF-1 also participates in the
regulation of the expression of genes encoding enzymes
involved in the de novo synthesis of cholesterol in
steroidogenic tissues [19]. It is known that ACTH regulates
the expression of steroidogenic genes via the PKA sig-
nalling pathway. However, it has not been established
whether ACTH regulates the expression of SF-1. Our
studies in the human adrenocortical cell line H295R pro-
vided evidence that the activators of the PKA pathway
induce the expression of LIPE via SF-1 [20]. Activators of
the PKC signalling pathway, such as phorbol esters and
angiotensin II, cause an increase in the expression of HDL
receptor (SR-B1) and slightly increase the transcriptional
activity of the gene encoding the LDL receptor [21]. It is
also possible that the activators of PKC affect the expres-
sion of SF-1 and the genes encoding enzymes of the
steroidogenic pathway, including HSL. Although the
mechanism of interaction of PKA with PKC has not been
elucidated, it is known that TPA is capable of reducing the
activity of the PKA pathway through activation of PKC
[21].
The aim of this study was to examine whether or not SF-
1 expression is regulated by PKA and to clarify the putative
role of SF-1in the PKA-induced expression of LIPE.
Experimental procedure
Cell culture
Mouse adrenocortical cells (line Y-1), obtained from the
American Type Culture Collection (Manassas, VA, USA),
were cultured in Ham’s F-12/DMEM 1:1 (v/v) containing
2.5 mM glutamine and supplemented with 10 % foetal
bovine serum (FBS), and antibiotic/antimycotic (ABAM)
containing 100 U/ml penicillin, 1 mg/ml streptomycin and
100 U/ml nystatin, all from Sigma-Aldrich (USA).
Incubation of Y-1 cells with test substances
After confluence was reached, the cells were given fresh
medium (as above) without FBS. After 24-h incubation, the
following substances were added: 25 lM forskolin (acti-
vator of adenylyl cyclase), 20 lM H-89 (inhibitor of pro-
tein kinase A) and 10 lM tetradecanoyl phorbol acetate
(TPA; activator of protein kinase C), and the incubation
was conducted for 24 h. After incubation, the cells were
washed with PBS and subjected to further analyses.
Isolation of RNA, reverse transcription
and amplification of cDNA
RNA was isolated according to the phenol–chloroform
method [22] using TRItidy reagent (Applichem, Germany).
One lg of RNA was then reverse transcribed with the use
of MMLV transcriptase and random hexamers (Novazym,
Poznan, Poland), and the concentrations of the SF1 and the
LIPE transcripts were estimated by RT-qPCR with the use
of the LightCycler 1.0 System (Roche Diagnostics, Ger-
many) and the designed primers (Table 1). The results of
RT-qPCR analysis were normalized to MRPL19 transcript
(from the mitochondrial ribosomal protein L19).
Estimation of LIPE promoter activity using dual
luciferase system
Using FuGene HD reagent (Roche Diagnostics, Germany),
cells were transfected with the expression vector pCMV-
SF1 containing the SF-1 gene and co-transfected with two
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other constructs: the reporter vector pGL3 harbouring
Firefly luciferase gene under the control of -343, or
-2150 bp fragment of LIPE promoter A, and the pRL-TK
vector, containing Renilla luciferase gene and used to
correct for transfection efficiency. After transfection, the
cells were incubated for 24 h, harvested and lysed, and the
luciferase activity was determined using the Dual Luci-
ferase System (Promega, USA) and a 20/20n Luminometer
(Turner Biosystems, USA).
Preparation of the nuclear extract
and electrophoretic mobility shift assay (EMSA)
Nuclear extract was prepared by lysing Y-1 cells in low-
salt buffer [100 mM HEPES pH 7.9, 15 mM MgCl2,
100 mM KCl, 0.1 M dithiothreitol (DTT)] and the protease
inhibitor (PMSF). After separation of the cytosol by cen-
trifugation, the nuclear fraction was extracted with high-
salt buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2,
0.42 M NaCl, 0.2 mM EDTA, 20 % glycerol, 0.1 M DTT)
and PMSF, mixed and centrifuged at 13,0009g for 5 min
and the supernatant was used for the assay.
The double-stranded oligonucleotide:
50-GCCGCCAAGGTCTCAGGCAAGGTCAGGGAC-
30, covering the SF-1 binding sites (underlined) within the
LIPE promoter A, was labelled with Cy5. The binding reac-
tion contained 10 lg of protein in 59 binding buffer (60 mM
HEPES, 20 mM Tris–HCl pH 8.0, 300 mM KCl, 5 mM
EDTA, 5 mM EGTA, 60 % glycerol, 1 lg poly(dC); 1 %
BSA and 25 mM DTT). The reaction mixture was incubated
for 20 min at 4 C and, after adding the labelled probe
(1 pmol/ll), for another 30 minunder the same conditions. To
verify the specificity of oligonucleotide binding to SF-1, the
control reactions contained a 1:1 v/v mixture of labelled and
unlabelled probes. Protein–DNA complexes were subjected
to electrophoresis on non-denaturing 4 % polyacrylamide gel
for 2.5 h at 75 V, and the labelled bands were visualized in a
laser scanner FLA-5100 (FUJIFILM, Japan). Immediately
after electrophoresis the gel was subjected to Western blot
analysis using antibody directed against SF-1, followed by a
HRP-conjugated secondary antibody (Santa Cruz Biotech-
nology, USA) and determination of peroxidase activity.
SF-1 silencing and determination of LIPE
expression
Silencing of SF-1 expression was achieved by 24-h incu-
bation of the cells transfected with a mixture of three
siRNAs (Santa Cruz Biotechnology, USA) complementary
to the SF-1 transcript. The effectiveness of silencing on the
LIPE transcript level was determined by RT-qPCR, while
on the SF-1 protein level the determination was made via
Western blotting employing anti-SF-1 antibody and horse
radish peroxidase-conjugated anti-c-globulin (Santa Cruz
Biotechnology, USA) for detection.
Statistical analysis
The results were analysed with the aid of GraphPad InStat
v.3.05 (La Jolla, CA, USA) and Microsoft Excel 2007. The
results are the mean ± SEM of three independent experi-
ments. To estimate the influence of test substances on the
level of transcripts, one-way ANOVA or two-way ANOVA
tests were applied. Significance of the differences between
individual samples was tested at the level of *P\ 0.05,
**P\ 0.01 or ***P\ 0.001.
Results and discussion
The PKA but not the PKC pathway regulates
transcription of SF-1
To investigate the effect of the PKA signalling pathway on
the expression of SF-1, ACTH was replaced by forskolin,
an activator of adenylate cyclase, whose effect on Y-1 cells
was earlier established [23, 24]. Y-1 cells were incubated
with forskolin, and after 24-h incubation, a three-fold
Table 1 Oligonucleotide
primers used for RT-qPCR
Primer name Primer sequence Amplicon length (bp)
mSF-1 F 50-TACTGGACAGGAGGTGGA-30 142
mSF-1 R 50-GAACTTGAGACAGACGAAC-30
mLIPE F 50-TCCAAGCAGGGCAAAGAAG-30 109
mLIPE R 50-GTGTCATCGTGCGTAAATCC-30
mMRPL19 F 50-AAGACGAGAGAAGGTTCCTG-30 170
mMRPL19 R 50-TAGGGGTCGGCTGTGGTG-30
Primers were designed using Oligo v.6.71 software, and DNA sequences were obtained from GenBank
(http://www.ncbi.nlm.nih.gov/nuccore/)
F forward, R reverse
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increase in the level of SF-1 transcript was observed. This
was accompanied by a substantial increase in the protein
product of the gene (not shown). This effect was abolished
when the cells were incubated with a selective inhibitor of
the PKA, H-89 (Fig. 1). Although the regulation of SF-1
transcription by ACTH or cAMP in adrenocortical cells
was previously investigated [25–28], the results from dif-
ferent studies were contradictory. In the mid-1990s, it was
shown that in response to stimulation by forskolin or
overexpression of the PKA catalytic subunit in Y-1 cells,
the level of SF-1 protein increases, while the SF-1 tran-
script level remains the same [25]. However, SF-1 tran-
script levels were elevated in bovine adrenal cortex cells
under identical conditions [26, 27]. The findings reported
here are similar to those obtained in mouse and in bovine
adrenocortical cells [28], but they are contradictory to the
results reported by other laboratories investigating Y-1
cells, e.g. [29]. Such discrepancies may be due to high
heterogeneity of Y-1 cell lines, especially their response to
stimulation of the PKA signalling pathway [30].
It was previously established that the protein kinase C
(PKC) pathway regulates the expression of some genes
involved in steroidogenesis. Activators of the PKC path-
way, such as phorbol esters and angiotensin II, enhance the
expression of SR-B1 and slightly increase the transcrip-
tional activity of the gene encoding LDL receptor [21]. We
therefore propose that, as in the case of other genes
involved in steroidogenesis, PKC might affect SF-1
expression. Moreover, we hypothesize that there is an
interaction between the PKA and the PKC pathways. In
order to answer these questions, Y-1 cells were incubated
with forskolin, TPA and with the activators of both kinases.
Activation of PKC did not change the level of SF-1 tran-
script (Fig. 1) indicating that the PKC pathway had no
effect on the transcriptional activity of SF-1. Interestingly,
simultaneous activation of PKA and PKC resulted in a
lower level of SF-1 transcript, suggesting an interaction
between both pathways. It is known that PKC induces the
expression of the gene encoding phosphodiesterase, which
hydrolyses cAMP [21]. Therefore, PKA-stimulated SF-1
transcription is probably inhibited through decreasing
cAMP level.
SF-1 stimulates transcriptional activity of LIPE
promoter A via the PKA pathway
Since SF-1 is a principal transcription factor involved in
the regulation of expression of numerous steroidogenic
genes [2], we presumed that it may also regulate the
expression of LIPE. In order to investigate SF-1-dependent
regulation of LIPE transcriptional activity, the cells were
transfected with the vector containing Firefly luciferase
gene under the control of the -343 or -2150 fragments of
LIPE promoter A and co-transfected with the vector
expressing SF-1. After 24-h incubation, the luciferase
activity was determined and normalized to the transfection
efficiency measured by the Renilla luciferase activity. SF-1
overexpression resulted in an almost three-fold increase in
the transcriptional activity of the -2150 fragment of LIPE
promoter A, while there was no significant effect of SF-1
on the transcriptional activity of the -343 fragment
(Fig. 2a). These results strengthen our observation,
obtained from the computer analysis of the DNA sequence
of LIPE promoter A, that within the region ranging from
the -343 to -2150 bp, there are two SF-1-binding sites
located within the -1400 to -1420 bp region which sig-
nificantly affect LIPE activity.
Based on these results, we utilized EMSA to examine
whether SF-1 binds directly to the LIPE promoter. For
this purpose, we used the Cy5-labelled oligonucleotide
corresponding to the SF-1 binding sites within the pro-
moter fragment. The 50-end-labelled oligonucleotide was
incubated with 10 lg of the nuclear extract from the Y-1
cells either alone or with the mixture of 1:1 labelled and
unlabelled oligonucleotide. As a negative control, the
probe was also incubated without the nuclear extract.
Formation of DNA–protein complexes was then moni-
tored by electrophoresis on non-denaturing polyacry-
lamide gels. The formation of DNA–protein complexes
was greatly reduced by the addition of unlabelled
Fig. 1 Effects of protein kinase A (PKA) and protein kinase C (PKC)
stimulation on the expression of SF-1 in Y-1 cells. Y-1 cells were
incubated for 12 h with or without (control) forskolin (an activator of
the PKA pathway), or with or without (control) tetradecanoyl phorbol
acetate (TPA; an activator of PKC pathway). The incubation was
followed by RNA extraction and estimation of the SF1 transcript
concentration by RT-qPCR. C no additions (control), F forskolin, H-
89 PKA inhibitor, TPA tetradecanoyl phorbol acetate. The results are
the mean of three independent experiments ± SEM. The effect of
forskolin on the concentration of SF-1, estimated by Western blotting,
is shown in the inset
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oligonucleotide of the same sequence (Fig. 2b). In order
to confirm the presence of SF-1 in the DNA–protein
complexes, Western blot analysis using antibody directed
against SF-1 was conducted (Fig. 2c) and confirmed the
direct binding of SF-1 to the response element within the
LIPE promoter A.
The results of our experiments clearly indicate that
SF-1 is involved in the regulation of LIPE expression.
However, the significance of SF-1 in PKA-dependent
regulation has not been established. In order to demon-
strate the significance of SF-1 in PKA-dependent LIPE
expression, Y-1 cells were transfected with siRNA
complementary to the SF-1 transcript resulting in a sig-
nificant decrease in the SF-1 protein 24 h after the
transfection. In order to evaluate whether or not the
deficiency of SF-1 affects the PKA-dependent expression
of LIPE, control cells and the SF-1-silenced Y-1 cells
were incubated for 6 h with forskolin resulting in a two-
fold increase in LIPE expression in the control cells
(Fig. 3). The silencing of SF-1 caused a significant
inhibition of PKA-dependent LIPE expression in our
experiments, suggesting that SF-1 contributes to the
regulation of LIPE expression via the PKA pathway. We
have shown that the activation of PKA is a crucial step
in the stimulation of LIPE expression by SF-1 and that it
is a major determinant in regulating cholesterol esterase/
lipase expression in adrenocortical cells. However, the
nature of the PKA and PKC interactions in regulating
SF-1 expression in Y-1 cells still remains unknown and
requires further investigation.
Fig. 2 The influence of SF-1 overexpression on the transcriptional
activity of LIPE promoter (a) and the detection of SF-1 binding to
LIPE promoter (b, c). Y-1 cells were transfected with SF-1 expression
vector and co-transfected with the pGL3 vector harbouring either
-2150 or -340 fragment of LIPE promoter A, directing Firefly
luciferase expression. Following 12-h incubation with (black bars) or
without (white bars) the SF-1 expression vector, protein was extracted
and the luciferase (Luc) activity was determined by luminometry. The
results were corrected for efficiency of transfection with the Luc
reporter, by measuring the activity of co-transfected Renilla
luciferase. The results are the mean of three independent experi-
ments ± SEM. Nuclear extract (NE) from Y-1 cells was incubated
with a Cy5-labelled DNA probe covering SF-1 binding sites within
the LIPE promoter. The incubation was followed by the electrophore-
sis in polyacrylamide gel and visualization of the probe by
fluorescence (EMSA). c incubation without the probe (control). The
labelled protein–probe complexes were excised from the gel (b), and
the protein was subjected to electrophoresis, blotted onto a PVDF
membrane and reacted with an antibody directed against SF-1
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